House mark for a full line of pharmaceuticals; pharmaceuticals for human use, namely, pharmaceuticals for treatment and prevention of pain and allergic, inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions mediated via intracellular transport processes

Pharmaceutical research and development services